PharmExec Direct - Pharmaceutical Executive

ADVERTISEMENT

PharmExec Direct

Medtronic Wins Recommendation for Safer Drug-Eluting Stents

October 17, 2007

FDA advisory panel notes high efficacy—and no thrombosis after six months—in clinical trials. Nonetheless, Medtronic's stents will be under close postapproval watch.

Moody's Drops Credit Rating of Pharma Industry

October 17, 2007

The industry drops in a major ranking from stable to negative. The reasons: patent expirations, slow drug approvals, and likelihood of cash-draining acquisitions.

GSK to Pay $1 Billion for Synta Melanoma Drug

October 17, 2007

In a blockbuster codevelopment deal, GlaxoSmithKline gains rights to an innovative Phase III melanoma drug.

Big Pharma Forms Consortium for Drug Safety

October 3, 2007

Introducing the International Serious Adverse Events Consortium, a new industry group that wants to identify the molecular roots of serious drug reactions. SAEC's first targets: liver failure and serious skin rashes.

FDA Switches Up Senior Staff

October 3, 2007

Galson and Woodcock were named acting surgeon general and director of CDER, respectively. Industry vets weigh in on the appointments.

BMS Snags Biotech Firm Adnexus

October 3, 2007

Adnexus' protein-building technology could spell new drugs and big profits for BMS--if the drug development engine works.

GSK Boosts Flu Doses

September 19, 2007

Drug company increases vaccine supply by 10 million in advance of influenza season

House Passes Patent-Reform Legislation

September 19, 2007

Patent overhaul could cramp pharma industry?s style

Cephalon Issues Dear Doctor Letter for Fentora

September 19, 2007

Drugmaker updates information on the use and side effects of cancer pain medication

ADVERTISEMENT

Click here